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Abstract
Background: Hepatic inflammatory pseudotumor (IPT) is a rare disease which often mimics a malignant tumor and
is therefore often misdiagnosed and surgically resected. Recently, a concept of IgG4-related diseases (IgG4-RD) has
been proposed that is becoming widely recognized and includes IgG4-related hepatic IPT. Corticosteroids are widely
accepted as the standard treatment.
Case presentation: A 72-year-old Japanese man, who had been followed for ten years after surgery and
chemotherapy for treatment of hilar and lower bile duct cancers, developed intermittent fever and abdominal
pain and visited this hospital. Blood examinations revealed an inflammatory reaction, worsened glucose
intolerance, and an increased level of serum IgG4 (137 mg/dL). Computed tomography (CT) revealed a 5 cm-sized
mass in hepatic segment 7. Because of his cancer history, not only was a benign mass suspected, but there was also
the possibility of a recurrent biliary malignancy. Liver biopsy was performed and the histology met the criteria for
IgG4-related IPT. Corticosteroid therapy was initiated and his symptoms quickly resolved. However, two months
later, a repeat CT demonstrated that the hepatic mass had been replaced by an abscess. The abscess was initially
refractory, despite tapering corticosteroid treatment, controlling diabetes by intensive insulin therapy, administration of
antibiotics, and percutaneous abscess drainage. Finally, after six months, the condition resolved.
Conclusion: The diagnosis of hepatic IPT is sometimes difficult. To differentiate it from a malignant tumor, histological
examination is necessary. Although corticosteroids are recognized as the standard therapy, unexpected and critical
complications can develop in cases of IgG4-related hepatic IPT.
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Background
Hepatic inflammatory pseudotumor (IPT) is a rare entity
that has been thought to be a composition which develops
through a variety of pathogeneses, such as infections with
a virus [1] or bacteria [2, 3], congenital diseases [4],
gallstones [5], and chronic biliary inflammation [6].
This disease mimics a malignant tumor on clinical images,
and is therefore often misdiagnosed and surgically resected.
The concept of this disease has been further presented
after the disclosure of the concept of immunoglobulin G4
(IgG4)-related hepatic IPT [7]. Recently, a consensus
statement of IgG4-related diseases (IgG4-RD) has been
published, including IgG4-related hepatic IPT, and
corticosteroids are the most suitable treatment for this
disease [8–10]. The current report presents a rare case
of IgG4-related hepatic IPT that developed into an
abscess after corticosteroid therapy and needed long-term
therapy.
Case presentation
A Japanese man was being followed after he underwent
left hepatectomy and pancreatoduodenectomy for a
mucin-producing hilar cholangiocarcinoma (the postop-
erative pathological diagnosis was well differentiated
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papillary adenocarcinoma, T2, N0, M0, stage II by the
International Union Against Cancer TNM classification)
and lower bile duct carcinoma (the postoperative patho-
logical diagnosis was well differentiated papillary adeno-
carcinoma, T1, N0, M0, stage I) 10 years ago when he
was 62 years of age. He had also undergone chemoradia-
tion therapy during the year following surgery (external
radiation: total 50.4 Gy for four weeks, chemotherapy:
310 mg/day of continuous infusion of 5-fluorouracil for
three years). Follow up was continued after this chemo-
radiation management, and the patient’s course was un-
eventful without recurrence, except for new onset of
diabetes after surgery [serum hemoglobin A1c (HbA1c):
6.4–7.4 %, normal range: 4.6–6.2 %].
At the age of 72, this patient presented to the hospital
with complaints of intermittent fever and abdominal pain.
His laboratory data showed increasing levels of white
blood cells (WBCs) (17500 /μL, normal: 3900–9800 /μL),
alkaline phosphatase (421 U/L, normal: 115–359 U/L),
C-reactive protein (CRP) (8.99 mg/dL, normal: <0.3 mg/dL),
HbA1c (8.8 %), and IgG4 (137 mg/dL, normal: 48–
105 mg/dL). Serum levels of hepatobiliary enzymes,
carcinoembryonic antigen, carbohydrate antigen 19-9,
and α-fetoprotein were within the normal range. Com-
puted tomography (CT) revealed a 5-cm mass lesion in
hepatic segment 7 (Fig. 1a), but no remarkable findings
in the most commonly affected organs of IgG4-RD,
which include the pancreas, abdominal aorta, and kidney.
Based on magnetic resonance imaging enhanced with
gadoxetate sodium (Fig. 2) and ultrasonography enhanced
with perfluorobutane microbubble (Fig. 3), we considered
the possibility of a hepatic abscess and a metastatic re-
currence of cholangiocarcinoma. Ultrasonography (US)-
guided percutaneous needle biopsy (SuperCore™, 18
gauge, 15 cm, Sheeman, Osaka, Japan) was performed on
this hepatic mass. Histopathology of the biopsy specimen
demonstrated abundant inflammatory cell infiltration
surrounded by dense fibrous tissue, or so-called stori-
form fibrosis (Fig. 4a, b, c). No cancer cells were recog-
nized. On immunohistochemistry, >20 of IgG4-positive
plasma cells were counted per high power field (HPF)
(Fig. 4d) and the ratio of IgG4/IgG was 17.3 %. These
clinicopathological findings met the criteria of a possible





Fig. 1 Enhanced computed tomography (CT) at initial diagnosis (a),
two months after steroid initiation (b), and after percutaneous
drainage placement (c). Initial CT showing a 5 cm-sized hepatic mass
in segment 7 (a). Following CT after steroid initiation showing a
9.5 cm, multilocular abscess replacing the inflammatory pseudotumor
and containing fluid and gas with marginal enhancement (b). CT after
percutaneous drainage placement showing a minimized abscess
lesion (c)
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To avoid aggravation of the patient’s diabetes mellitus,
corticosteroids were initially not offered and he was
treated with antibiotics, non-steroidal anti-inflammatory
drugs, and ursodeoxycholic acid. However, the patient’s
symptoms continued, mandating that steroid therapy be
considered. The patient was offered the opportunity to
provide informed consent about expected outcomes and
possible adverse events. Oral steroid therapy was started
on admission to control blood glucose level by intensive
insulin therapy. The dose of prednisolone was 30 mg/day
for the first week, tapered by 5 mg per week until the dose
reached 10 mg/day, and further tapered in the decelerated
pitch (1 mg per week). Concerning about exacerbation of
his hyperglycemia, we accelerated the steroid tapering.
After treatment with oral steroids, he had no symptoms
and his laboratory data reached the nearly normal levels
(serum hepatic enzymes was normalized and CRP level
declined to 1.02 mg/dL) and the shrinkage of the IPT was
recognized by US. However, after three months from
starting the steroid tapering, his fever and abdominal pain
recurred afterward. Again, blood tests were abnormal as
follows: elevated levels of WBCs (15000 /μL with 94.1 %
neutrophils), CRP (12.7 mg/dL), HbA1c (9.5 %), but
normalized IgG4 (84.5 mg/dL). CT revealed an extensive
low-density area in the hepatic segment 7–8 (Fig. 1b).
The lesion was encapsulated by an enhanced wall and
contained gas and fluid. It was diagnosed as a hepatic
abscess. As we considered the liver abscess caused by
the steroid therapy, we continued to taper steroid
amount and stopped in one month after diagnosis of
the hepatic abscess. US-guided percutaneous abscess
drainage was performed, as well as antibiotic treatment
with ampicillin-sulbactam was started with 13.5 g of
daily dose and continued for 10 days. Klebsiella pneu-
moniae was isolated from both liver aspirates and blood
culture. Although his laboratory data improved and the
patient was discharged in 10 days, complete liquefac-
tion of the IPT component needed time and the abscess
was refractory. Percutaneous drainage was finally with-
drawn after confirming the shrinkage of the abscess at
the sixth month (Fig. 1c), and no sign of recurrence
was seen for the following 16 months.
Conclusion
In general, hepatic IPTs are difficult to differentiate
from malignant tumors, as their incidence is rare, their
pathogenesis is diverse, and imaging findings are varied
[1–4, 6, 7, 11]. In some cases, the images of hepatic
IPTs resemble metastases from distant origin tumors,
such as pancreatic cancer [12] and malignant gastro-
intestinal stromal tumors [13]. In contrast, some of the
hepatic tumors mimicking IPT in cases with IgG4-RD
have been revealed to be a recurrence of long-time la-
tent cancer confirmed by a percutaneous biopsy [14].
Hence, the histological confirmation of the hepatic
mass is critical, especially in cases with IgG4-RD or
those suspected of being hepatic IPT. One concern in
percutaneous liver biopsy is needle-tract seeding in pa-
tients with malignant tumors, which is recognized in
2.7 % of cases [15]. Therefore, caution is needed for the
selection of biopsy targets and unnecessary biopsies
should not be performed, for instance in cases of doubt-
less cancers presumed to be curative by resection.
From the viewpoints of differentiating their pathogenesis
or subtypes, biopsy is recommended in cases of a sus-
pected hepatic IPT. As described above, this tumor is
Fig. 2 Magnetic resonance imaging (MRI) at 15 min since contrast injection. MRI enhanced with gadoxetate sodium showing a faint uptake of
the contrast medium at the central area of the hepatic mass
Shibata et al. BMC Gastroenterology  (2016) 16:89 Page 3 of 6
caused by a variety of pathogeneses [1–7, 11], and their
histology is quite distinctive. For instance, follicular den-
dritic cell tumor is specific to Epstein-Barr virus infection
[1]; tuberculosis [3] is detectable by Ziehl-Neelsen staining
and typically causes caseating granulomas; and inflam-
matory myofibroblastic tumor is typically seen in the
lung and liver [16]. Culture samples can also be ob-
tained by biopsy in cases with a suspected infectious
background [2, 3]. In this sense, IgG4-related hepatic
IPT features fairly unique histology; that is to say abun-
dant IgG4-positive plasma cell infiltration (>10 cells/HPF
in biopsy and >50 cells in surgical materials) [8], stori-
form fibrosis, and obliterative phlebitis [8, 10, 17].
The sample obtained from current patient contained
diagnostic items fulfilling the criteria of possible
IgG4-RD [8, 10] and percutaneous needle biopsy is
thought to be an effective diagnostic tool for IgG4-
related hepatic IPT.
According to a keyword search in PubMed, a total of
11 cases of IgG4-related hepatic IPT were identified
[11, 18–23] (Table 1). Including the case in this study,
the patients were all men with an average age of
64.8 years (range: 52–77 years). The ratio of a solitary
tumor was 91.7 % (11out of 12 cases) and the mean
tumor diameter was 3.3 cm (range: 1.4–7.7 cm). The lo-
cation of the tumors did not show any significant trend.
In the cases with available data, the median of serum
IgG4 level was 213 mg/dL and the patients showing el-
evated serum IgG4 (>135 mg/dL) accounted for 85.7 %
(6/7). This high incidence of serum IgG4 elevation can
be a hint for further examinations of IgG4-RD. In
addition, hepatic IPT is not infrequently associated with
IgG4-related sclerosing cholangitis, the patients showing
sclerosing cholangitis accounted for 50 % (3/6) in our
research. Hepatic IPT may represent local inflammatory
changes of cholangitis [6]. As most of these cases had
a
cb
Fig. 3 Enhanced ultrasonography using perfluorobutane microbubble. An irregular-margin of low echoic mass depicted by B-mode image (a).
The lesion infused by microbubble at 10 s after contrast injection (b). Defected microbubble enhancement at 20 s (c)
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already been reported before the publication of a con-
sensus statement on IgG4-RD [8], it is unclear how
many of them satisfied the diagnostic criteria [18]. Future
study is warranted to clarify the clinical characteristics of
IgG4-related hepatic IPT to facilitate its diagnosis.
To date, adverse events related to corticosteroid therapy
for IgG4-RD have rarely been reported. In the present
case, several concerns were raised about steroid treatment,
such as worsening blood glucose control, immunocom-
promisation, obesity, osteoporosis, ophthalmologic dis-
eases (cataract and glaucoma) and steroid withdrawal
syndrome. In autoimmune pancreatitis or one of the most
popular subtypes of IgG4-RD, many cases actually show
improvement in diabetes by steroid treatment [24], as they
are cases of pancreatic diabetes. The current patient with
diabetes and immunocompromised condition is at an
increased risk of developing a pyogenic hepatic abscess
[25]. This abscess, which originally consisted of dense
fibrous tissue, took a long time (six months) to resolve,
probably due to associated diabetes, immunocomprom-
ised status, and slow liquefaction of the mass. The clin-
ician must be cautious about the possible adverse events
associated with corticosteroids for the treatment of
IgG4-related hepatic IPT.
The diagnosis of hepatic IPT is difficult, especially in
terms of differentiation from malignant tumors. Histo-
logical diagnosis is essential and percutaneous needle bi-
opsy is effective for the diagnosis of IgG4-related IPT.
Fig. 4 Histological view of the hepatic biopsy. Low power view (a) and high power view (b) of hematoxylin and eosin (HE) staining. CD68 protein
diffusely expressed in numerous number of macrophages and storiform fibrosis (CD68) (c). Increased number of IgG4-positive cells infiltrating in the
fibrous tissue (IgG4) (d)
Table 1 Summary of the reported cases of IgG4-related hepaticinflammatory pseudotumor
Author Year Age(y.o.)/Sex Serum IgG4 Number of IPT Size Location Biopsy Resection IgG4-RD
Uchida K [19] 2007 54/M 213 mg/dL 1 3 cm Segment 4 Done Pancreatitis
Naito I [11] 2009 77/M 231 mg/dL 1 4 cm Segment 3 done Sclerosing cholangitis
Kim F [20] 2011 58/M 1470 mg/dL 1 3 cm Segment 4 Done Tubulointerstitial nephritis
Horiguchi S [21] 2012 76/M 819 mg/dL 1 1.5 cm Segment 2 Done Sclerosing cholangitis
Ahn KS [18] 2012 58/M NA 1 3 cm NA done NA
Ahn KS [18] 2012 60/M NA 1 7.7 cm NA done NA
Ahn KS [18] 2012 76/M NA 2 2.3 cm NA Done NA
Ahn KS [18] 2012 52/M NA 1 4 cm NA Done NA
Lee YS [22] 2013 59/M 75 mg/dL 1 NA Segment 5 Done Sclerosing cholangitis
Matsuo Y [13] 2014 74/M NA 1 1.4 cm Segment 8 done NA
Yang L [23] 2015 60/M 159 mg/dL 1 NA Segment 3 Done Esophageal mass, gastric ulcer
Our Case 2015 73/M 137 mg/dL 1 3 cm Segment 7–8 Done None
M male, NA data not available
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Clinicians must bear in mind that corticosteroid treatment
is not always ideal and may cause critical adverse events in
cases with IgG4-RD.
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